Loomis, Sayles & Company’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-94,406
| Closed | -$16.2M | – | 940 |
|
|
2021
Q3 | $16.2M | Buy |
+94,406
| New | +$16.2M | 0.02% | 330 |
|
|
2021
Q1 | – | Sell |
-93
| Closed | -$12K | – | 919 |
|
|
2020
Q4 | $12K | Buy |
+93
| New | +$12K | ﹤0.01% | 705 |
|
|
2017
Q1 | – | Sell |
-370,424
| Closed | -$9.45M | – | 1058 |
|
|
2016
Q4 | $9.45M | Buy |
+370,424
| New | +$9.45M | 0.02% | 444 |
|
|
2015
Q2 | – | Sell |
-357,413
| Closed | -$13.6M | – | 952 |
|
|
2015
Q1 | $13.6M | Sell |
357,413
-24,392
| -6% | -$928K | 0.04% | 426 |
|
|
2014
Q4 | $14.9M | Sell |
381,805
-19,365
| -5% | -$754K | 0.04% | 428 |
|
|
2014
Q3 | $12.1M | Sell |
401,170
-10,611
| -3% | -$321K | 0.04% | 463 |
|
|
2014
Q2 | $14M | Buy |
411,781
+123,407
| +43% | +$4.19M | 0.04% | 445 |
|
|
2014
Q1 | $9.95M | Buy |
+288,374
| New | +$9.95M | 0.03% | 495 |
|